Answers are grounded in this paper and cite their sources.
Evaluates adherence and safety of inebilizumab in NMOSD, suggesting effective treatment options.
This study aimed to evaluate the safety and treatment adherence of inebilizumab in patients with neuromyelitis optica spectrum disorder (NMOSD).
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: